PHENYTOIN SODIUM

PHENYTOIN SODIUM was reported 16673 times

PHENYTOIN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CORNEAL TOUCH 3 0.6000
1 PURPLE GLOVE SYNDROME 28 0.2137
2 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 59 0.0784
3 ANTICONVULSANT DRUG LEVEL DECREASED 86 0.0609
4 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 31 0.0477
5 ANTICONVULSANT DRUG LEVEL INCREASED 70 0.0433
6 ECHINOCOCCIASIS 3 0.0411
7 BARBITURATES POSITIVE 3 0.0375
8 CEREBELLAR ATROPHY 26 0.0295
9 ANTICONVULSANT DRUG LEVEL ABNORMAL 5 0.0284
10 SKIN GRAFT FAILURE 3 0.0283
11 DRUG LEVEL FLUCTUATING 25 0.0282
12 ARTERIOGRAM CORONARY ABNORMAL 2 0.0274
13 HYSTEROSALPINGO-OOPHORECTOMY 3 0.0268
14 VENTRICULAR ASYSTOLE 4 0.0230
15 ANTITHROMBIN III DEFICIENCY 2 0.0225
16 BLOOD 1,25-DIHYDROXYCHOLECALCIFEROL INCREASED 2 0.0217
17 BONE HYPERTROPHY 3 0.0186
18 GINGIVAL HYPERTROPHY 26 0.0171
19 BLADDER REPAIR 3 0.0164
20 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 6 0.0158
21 OPSOCLONUS MYOCLONUS 3 0.0141
22 CEREBELLAR ATAXIA 12 0.0125
23 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 4 0.0125
24 NYSTAGMUS 65 0.0122
25 INFUSION SITE THROMBOSIS 3 0.0112
26 DRUG LEVEL CHANGED 7 0.0111
27 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 31 0.0095
28 ATAXIA 112 0.0094
29 NODAL ARRHYTHMIA 8 0.0093
30 STATUS EPILEPTICUS 100 0.0088
31 PSEUDOSTROKE 3 0.0087
32 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 4 0.0085
33 SINOATRIAL BLOCK 5 0.0084
34 DRUG LEVEL ABNORMAL 4 0.0075
35 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 4 0.0075
36 SJS-TEN OVERLAP 5 0.0071
37 DRUG LEVEL DECREASED 71 0.0070
38 OPHTHALMOPLEGIA 11 0.0070
39 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 2 0.0069
40 CATARRH 6 0.0066
41 GRAND MAL CONVULSION 60 0.0065
42 COMPLEX PARTIAL SEIZURES 7 0.0063
43 TINEA CRURIS 3 0.0060
44 ARRHYTHMIC STORM 2 0.0060
45 CHOREOATHETOSIS 4 0.0059
46 INFUSION SITE VESICLES 3 0.0057
47 STRESS URINARY INCONTINENCE 6 0.0056
48 MULTIPLE-DRUG RESISTANCE 17 0.0055
49 EXTENSOR PLANTAR RESPONSE 5 0.0054
50 CONTRAINDICATED PRODUCT PRESCRIBED 9 0.0054
51 GRIMACING 4 0.0051
52 CONVULSION 291 0.0051
53 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 21 0.0051
54 GINGIVAL HYPERPLASIA 3 0.0050
55 SIMPLE PARTIAL SEIZURES 4 0.0050
56 PETIT MAL EPILEPSY 24 0.0047
57 MYOCLONIC EPILEPSY 7 0.0046
58 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 5 0.0045
59 HYPERAMMONAEMIA 22 0.0044
60 EYE ROLLING 3 0.0042
61 ILLUSION 7 0.0042
62 CEREBELLAR SYNDROME 9 0.0041
63 CLONIC CONVULSION 3 0.0041
64 CHOREA 7 0.0041
65 EPILEPSY 124 0.0041
66 ELECTROCARDIOGRAM PR PROLONGATION 3 0.0039
67 FULMINANT TYPE 1 DIABETES MELLITUS 4 0.0039
68 DRUG LEVEL BELOW THERAPEUTIC 21 0.0038
69 AURA 7 0.0037
70 DIABETES INSIPIDUS 9 0.0037
71 INTENTIONAL MISUSE 7 0.0037
72 ERYTHRODERMIC PSORIASIS 3 0.0036
73 PERITONEAL DIALYSIS 3 0.0036
74 SEIZURE CLUSTER 3 0.0036
75 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 92 0.0036
76 STEVENS-JOHNSON SYNDROME 79 0.0035
77 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
78 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
79 HYPERPLASIA 3 0.0033
80 SUPERINFECTION 5 0.0033
81 MUCOSAL EROSION 3 0.0033
82 INFUSION SITE WARMTH 4 0.0033
83 SEIZURE 363 0.0031
84 TOXIC EPIDERMAL NECROLYSIS 47 0.0031
85 HYPOCOAGULABLE STATE 3 0.0031
86 DRUG TOXICITY 41 0.0030
87 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
88 BONE DEFORMITY 2 0.0030
89 MALABSORPTION 15 0.0029
90 HYPERREFLEXIA 10 0.0029
91 PARTIAL SEIZURES 15 0.0029
92 JOINT CONTRACTURE 3 0.0028
93 ERYTHEMA MULTIFORME 26 0.0028
94 BLOOD FOLATE DECREASED 2 0.0028
95 SEDATION COMPLICATION 7 0.0027
96 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 2 0.0027
97 POTENTIATING DRUG INTERACTION 9 0.0027
98 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
99 FOCAL DYSCOGNITIVE SEIZURES 3 0.0026
100 DRUG LEVEL ABOVE THERAPEUTIC 12 0.0026
101 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 2 0.0026
102 BLOOD KETONE BODY INCREASED 2 0.0026
103 SINUS ARREST 4 0.0025
104 TRISMUS 13 0.0025
105 BARRETT'S OESOPHAGUS 2 0.0025
106 FOAMING AT MOUTH 5 0.0025
107 PHARMACEUTICAL PRODUCT COMPLAINT 63 0.0024
108 TONGUE BITING 5 0.0024
109 DRUG LEVEL INCREASED 40 0.0024
110 THERAPEUTIC AGENT TOXICITY 8 0.0024
111 REACTION TO DRUG EXCIPIENTS 5 0.0023
112 OBLITERATIVE BRONCHIOLITIS 3 0.0023
113 ELECTROENCEPHALOGRAM ABNORMAL 7 0.0022
114 ANAEMIA OF CHRONIC DISEASE 2 0.0022
115 CEREBRAL VENOUS THROMBOSIS 4 0.0022
116 FRACTURE NONUNION 3 0.0022
117 INGROWING NAIL 5 0.0021
118 PORPHYRIA ACUTE 3 0.0021
119 AGITATION NEONATAL 2 0.0021
120 HYPOREFLEXIA 4 0.0021
121 COMA SCALE ABNORMAL 6 0.0021
122 CLEFT PALATE 4 0.0021
123 BONE SWELLING 2 0.0021
124 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
125 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18 0.0020
126 CEREBRAL ATROPHY 8 0.0020
127 HYPERNATRAEMIA 10 0.0020
128 MIXED LIVER INJURY 6 0.0020
129 COMPARTMENT SYNDROME 5 0.0019
130 VENTRICULAR ARRHYTHMIA 7 0.0019
131 DILATATION VENTRICULAR 4 0.0019
132 STUPOR 6 0.0019
133 BEHAVIOUR DISORDER 10 0.0018
134 OEDEMA MOUTH 6 0.0018
135 BRADYARRHYTHMIA 3 0.0018
136 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 6 0.0018
137 DRUG SCREEN FALSE POSITIVE 5 0.0018
138 RASH MORBILLIFORM 5 0.0018
139 AMMONIA INCREASED 9 0.0018
140 GAZE PALSY 3 0.0018
141 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
142 EXTRAVASATION 7 0.0017
143 DYSARTHRIA 64 0.0017
144 ACUTE LUNG INJURY 2 0.0017
145 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
146 HEPATITIS FULMINANT 5 0.0017
147 STARING 4 0.0017
148 DRUG INTERACTION 262 0.0016
149 LOBAR PNEUMONIA 3 0.0016
150 BLOOD UREA DECREASED 2 0.0016
151 BLOOD BLISTER 5 0.0016
152 HYPERPARATHYROIDISM SECONDARY 4 0.0016
153 BRADYCARDIA NEONATAL 2 0.0016
154 GRANULOCYTOPENIA 9 0.0016
155 VARICOSE VEIN 8 0.0015
156 AREFLEXIA 4 0.0015
157 ACCIDENTAL POISONING 2 0.0015
158 APLASIA PURE RED CELL 5 0.0015
159 HYPERKINESIA 3 0.0014
160 TOXICITY TO VARIOUS AGENTS 238 0.0014
161 LYMPHOCYTOSIS 3 0.0014
162 TOXIC ENCEPHALOPATHY 7 0.0014
163 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
164 STRIDOR 4 0.0014
165 FEELING DRUNK 10 0.0013
166 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 3 0.0013
167 IDIOPATHIC INTRACRANIAL HYPERTENSION 3 0.0013
168 CATATONIA 7 0.0013
169 ASTIGMATISM 2 0.0013
170 EYE INJURY 4 0.0013
171 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
172 REACTION TO EXCIPIENT 3 0.0013
173 BRAIN DEATH 4 0.0013
174 COORDINATION ABNORMAL 18 0.0013
175 BLOOD ALBUMIN DECREASED 10 0.0013
176 LYMPHADENITIS 3 0.0012
177 MULTIPLE DRUG OVERDOSE 6 0.0012
178 CYTOLYTIC HEPATITIS 4 0.0012
179 HAEMODYNAMIC INSTABILITY 9 0.0012
180 PARKINSON'S DISEASE 3 0.0012
181 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
182 MYOCLONUS 14 0.0012
183 MEDICATION RESIDUE 3 0.0012
184 BLOOD CHLORIDE INCREASED 2 0.0012
185 HAEMATOTOXICITY 11 0.0012
186 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
187 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
188 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
189 THROMBOPHLEBITIS 4 0.0011
190 LUNG OPACITY 3 0.0011
191 BRONCHIOLITIS 4 0.0011
192 CONJUNCTIVAL HYPERAEMIA 4 0.0011
193 FACIAL BONES FRACTURE 4 0.0011
194 BLOOD PHOSPHORUS INCREASED 3 0.0011
195 TOXIC SKIN ERUPTION 11 0.0011
196 NEUROTOXICITY 19 0.0011
197 EOSINOPHILIA 19 0.0011
198 NEPHROGENIC ANAEMIA 5 0.0011
199 RASH MACULO-PAPULAR 24 0.0011
200 BRADYCARDIA 57 0.0011
201 DRUG ERUPTION 19 0.0011
202 BONE MARROW TRANSPLANT 2 0.0011
203 PULSE ABSENT 5 0.0011
204 SUBDURAL HAEMATOMA 15 0.0010
205 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
206 VITAMIN B12 DECREASED 3 0.0010
207 GINGIVAL DISORDER 4 0.0010
208 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
209 ATROPHY 2 0.0010
210 ABDOMINAL WALL HAEMATOMA 2 0.0010
211 STAPHYLOCOCCAL SEPSIS 5 0.0010
212 HISTIOCYTOSIS HAEMATOPHAGIC 3 0.0010
213 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
214 DIPLOPIA 26 0.0010
215 DERMATITIS EXFOLIATIVE 5 0.0010
216 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
217 HYPERCAPNIA 3 0.0010
218 TRIGEMINAL NEURALGIA 4 0.0010
219 NEPHROGENIC SYSTEMIC FIBROSIS 3 0.0010
220 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
221 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
222 ATRIAL THROMBOSIS 2 0.0010
223 FAMILY STRESS 3 0.0010
224 DERMATITIS BULLOUS 7 0.0010
225 AKINESIA 2 0.0010
226 APLASTIC ANAEMIA 5 0.0010
227 HAEMODIALYSIS 8 0.0010
228 NON-CARDIAC CHEST PAIN 3 0.0009
229 HEAD INJURY 30 0.0009
230 ANAEMIA MACROCYTIC 2 0.0009
231 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
232 PEMPHIGOID 7 0.0009
233 INTESTINAL ISCHAEMIA 5 0.0009
234 NECROSIS 5 0.0009
235 DYSKINESIA 36 0.0009
236 SUBARACHNOID HAEMORRHAGE 9 0.0009
237 GENERALISED ERYTHEMA 5 0.0009
238 EYE MOVEMENT DISORDER 6 0.0009
239 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
240 BRAIN NEOPLASM 8 0.0009
241 ENCEPHALITIS 6 0.0009
242 HYPOMAGNESAEMIA 12 0.0009
243 MYDRIASIS 11 0.0009
244 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
245 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
246 VENTRICULAR TACHYCARDIA 14 0.0008
247 ODYNOPHAGIA 5 0.0008
248 PRODUCT SUBSTITUTION ISSUE 48 0.0008
249 BALANCE DISORDER 72 0.0008
250 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
251 ATELECTASIS 8 0.0008
252 CARDIOMEGALY 10 0.0008
253 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
254 ACUTE PSYCHOSIS 2 0.0008
255 DIABETIC NEUROPATHY 4 0.0008
256 SEDATION 21 0.0008
257 IMPULSIVE BEHAVIOUR 3 0.0008
258 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
259 MULTIPLE INJURIES 5 0.0008
260 MUSCLE ATROPHY 10 0.0008
261 THERAPEUTIC RESPONSE CHANGED 5 0.0008
262 DYSLIPIDAEMIA 4 0.0008
263 COMMUNICATION DISORDER 3 0.0008
264 ANGLE CLOSURE GLAUCOMA 2 0.0008
265 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
266 DRUG RESISTANCE 20 0.0008
267 UNRESPONSIVE TO STIMULI 20 0.0008
268 INCOHERENT 5 0.0008
269 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
270 RESPIRATORY ACIDOSIS 3 0.0008
271 PNEUMONIA ASPIRATION 19 0.0008
272 INCONTINENCE 8 0.0008
273 PATENT DUCTUS ARTERIOSUS 3 0.0008
274 TRICUSPID VALVE INCOMPETENCE 6 0.0008
275 ANGIONEUROTIC OEDEMA 2 0.0007
276 ALCOHOL ABUSE 2 0.0007
277 MUSCLE HAEMORRHAGE 3 0.0007
278 INTRACRANIAL ANEURYSM 3 0.0007
279 ALCOHOL POISONING 2 0.0007
280 CYSTITIS HAEMORRHAGIC 3 0.0007
281 ENURESIS 3 0.0007
282 BLOOD SODIUM INCREASED 2 0.0007
283 HYPOCALCAEMIA 14 0.0007
284 TACHYPNOEA 10 0.0007
285 DEMYELINATION 3 0.0007
286 DRUG DISPENSING ERROR 11 0.0007
287 LEUKOCYTOSIS 13 0.0007
288 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
289 BLOOD UREA INCREASED 12 0.0007
290 ONYCHOMADESIS 3 0.0007
291 ANGIOPATHY 4 0.0007
292 SLEEP TERROR 3 0.0007
293 ATYPICAL FEMUR FRACTURE 2 0.0007
294 HEPATOCELLULAR INJURY 10 0.0007
295 THERMAL BURN 5 0.0007
296 UTERINE HAEMORRHAGE 3 0.0007
297 MENTAL IMPAIRMENT 17 0.0007
298 HEPATIC LESION 3 0.0007
299 HYPOTHERMIA 7 0.0007
300 HYPERVENTILATION 4 0.0007
301 HYPOKINESIA 10 0.0007
302 STRESS CARDIOMYOPATHY 4 0.0007
303 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
304 WHEELCHAIR USER 3 0.0007
305 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
306 URINARY TRACT DISORDER 3 0.0007
307 OSTEOPENIA 10 0.0007
308 ISCHAEMIA 3 0.0007
309 ENCEPHALOPATHY 16 0.0007
310 HYPERCALCAEMIA 8 0.0006
311 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 4 0.0006
312 HYPOALBUMINAEMIA 5 0.0006
313 CARDIAC ARREST 53 0.0006
314 TIBIA FRACTURE 3 0.0006
315 AGGRESSION 32 0.0006
316 MULTI-ORGAN FAILURE 11 0.0006
317 BLEPHAROSPASM 4 0.0006
318 BRAIN OEDEMA 8 0.0006
319 BLOOD DISORDER 5 0.0006
320 SKIN INFECTION 7 0.0006
321 HUMERUS FRACTURE 3 0.0006
322 ENTEROCOCCAL INFECTION 3 0.0006
323 VITAMIN D DEFICIENCY 6 0.0006
324 CONFUSIONAL STATE 99 0.0006
325 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
326 COMA 29 0.0006
327 DYSGRAPHIA 4 0.0006
328 ORGANISING PNEUMONIA 3 0.0006
329 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
330 COAGULOPATHY 10 0.0006
331 HYPOTHYROIDISM 19 0.0006
332 ECONOMIC PROBLEM 9 0.0006
333 ACUTE HEPATIC FAILURE 8 0.0006
334 PRODUCT COLOUR ISSUE 3 0.0006
335 ONYCHOCLASIS 4 0.0006
336 DISORIENTATION 23 0.0006
337 FOOT FRACTURE 11 0.0006
338 PERIORBITAL OEDEMA 3 0.0006
339 NERVOUS SYSTEM DISORDER 18 0.0006
340 DRUG-INDUCED LIVER INJURY 18 0.0006
341 SPEECH DISORDER 30 0.0006
342 RESPIRATORY DEPRESSION 7 0.0006
343 SPINAL OSTEOARTHRITIS 5 0.0006
344 SERUM FERRITIN INCREASED 3 0.0006
345 HAND FRACTURE 4 0.0006
346 HYPOTENSION 113 0.0006
347 FACIAL PAIN 5 0.0006
348 BRUXISM 3 0.0006
349 GINGIVITIS 3 0.0006
350 TONGUE DISORDER 4 0.0006
351 HYDROCEPHALUS 3 0.0006
352 DYSSTASIA 16 0.0005
353 ASPIRATION 6 0.0005
354 RESPIRATORY ARREST 15 0.0005
355 RESPIRATORY DISTRESS 15 0.0005
356 AMYLASE INCREASED 2 0.0005
357 MENTAL STATUS CHANGES 15 0.0005
358 ARTHROPOD BITE 4 0.0005
359 HEPATIC ENCEPHALOPATHY 5 0.0005
360 RIB FRACTURE 11 0.0005
361 LACERATION 5 0.0005
362 APHASIA 16 0.0005
363 NEUROLOGICAL SYMPTOM 3 0.0005
364 HYPERTHERMIA 4 0.0005
365 HYPERTONIA 3 0.0005
366 VISUAL DISTURBANCE 3 0.0005
367 CORONARY ARTERY BYPASS 3 0.0005
368 MUSCLE TWITCHING 12 0.0005
369 ENTEROCOLITIS 3 0.0005
370 ACCIDENTAL OVERDOSE 19 0.0005
371 SINUS BRADYCARDIA 5 0.0005
372 DYSTONIA 10 0.0005
373 APNOEA 4 0.0005
374 TREATMENT NONCOMPLIANCE 28 0.0005
375 LIP SWELLING 17 0.0005
376 HEPATOMEGALY 5 0.0005
377 CYANOSIS 8 0.0005
378 NEUROLEPTIC MALIGNANT SYNDROME 6 0.0005
379 ABNORMAL BEHAVIOUR 20 0.0005
380 MEDICATION ERROR 28 0.0005
381 PROTHROMBIN TIME PROLONGED 3 0.0005
382 AZOTAEMIA 2 0.0005
383 BRAIN INJURY 5 0.0005
384 BLOOD TEST ABNORMAL 7 0.0005
385 DRUG INTOLERANCE 48 0.0005
386 SOMNOLENCE 100 0.0005
387 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
388 MUSCLE DISORDER 4 0.0005
389 END STAGE RENAL DISEASE 9 0.0005
390 NO THERAPEUTIC RESPONSE 6 0.0005
391 POST PROCEDURAL INFECTION 4 0.0005
392 DECUBITUS ULCER 4 0.0005
393 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
394 LETHARGY 28 0.0005
395 OLIGURIA 3 0.0005
396 ILEUS 6 0.0005
397 BACTERIAL INFECTION 9 0.0005
398 TOOTH LOSS 10 0.0005
399 LIVER FUNCTION TEST ABNORMAL 14 0.0005
400 HEMIPLEGIA 4 0.0005
401 LYMPHADENOPATHY 17 0.0005
402 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
403 POISONING 6 0.0005
404 DRUG INEFFECTIVE 626 0.0005
405 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
406 HALLUCINATION, VISUAL 10 0.0005
407 NEUROPATHY PERIPHERAL 45 0.0005
408 HEMIPARESIS 8 0.0005
409 RENAL FAILURE ACUTE 20 0.0005
410 ROTATOR CUFF SYNDROME 6 0.0005
411 ABNORMAL SENSATION IN EYE 2 0.0005
412 POOR QUALITY DRUG ADMINISTERED 3 0.0005
413 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
414 AMNESIA 30 0.0005
415 BACK INJURY 5 0.0005
416 LOCAL SWELLING 8 0.0005
417 HYPOGAMMAGLOBULINAEMIA 3 0.0005
418 METASTASES TO LIVER 8 0.0005
419 PURPURA 4 0.0005
420 LUNG INFECTION 7 0.0005
421 VENTRICULAR FIBRILLATION 5 0.0004
422 TRANSAMINASES INCREASED 10 0.0004
423 GAIT DISTURBANCE 86 0.0004
424 WRONG DRUG ADMINISTERED 4 0.0004
425 SWOLLEN TONGUE 14 0.0004
426 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
427 MALNUTRITION 5 0.0004
428 MYOSITIS 4 0.0004
429 COLITIS ISCHAEMIC 3 0.0004
430 BLOOD CALCIUM DECREASED 5 0.0004
431 POSTOPERATIVE WOUND INFECTION 3 0.0004
432 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
433 OBESITY 7 0.0004
434 ECCHYMOSIS 3 0.0004
435 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
436 TREMOR 72 0.0004
437 PERSONALITY CHANGE 4 0.0004
438 ELECTROLYTE IMBALANCE 5 0.0004
439 FALL 143 0.0004
440 CAESAREAN SECTION 5 0.0004
441 LOSS OF CONSCIOUSNESS 55 0.0004
442 RASH MACULAR 15 0.0004
443 APPENDICITIS 4 0.0004
444 DEFORMITY 4 0.0004
445 ARTERIOSCLEROSIS 4 0.0004
446 RASH GENERALISED 11 0.0004
447 BLOOD SODIUM DECREASED 8 0.0004
448 LYMPHOPENIA 6 0.0004
449 DIVERTICULUM 3 0.0004
450 POISONING DELIBERATE 4 0.0004
451 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
452 HYPERSOMNIA 12 0.0004
453 HYPERLIPIDAEMIA 5 0.0004
454 MUSCLE RIGIDITY 5 0.0004
455 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
456 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
457 APHAGIA 2 0.0004
458 FACE OEDEMA 7 0.0004
459 RASH PUSTULAR 3 0.0004
460 ORAL DISORDER 3 0.0004
461 MOUTH HAEMORRHAGE 3 0.0004
462 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
463 PSYCHOTIC DISORDER 12 0.0004
464 CEREBRAL DISORDER 3 0.0004
465 URINARY INCONTINENCE 12 0.0004
466 HEPATIC FUNCTION ABNORMAL 15 0.0004
467 ANEURYSM 2 0.0004
468 UPPER LIMB FRACTURE 8 0.0004
469 HAEMORRHAGE INTRACRANIAL 6 0.0004
470 HYPOTONIA 4 0.0004
471 SALIVARY HYPERSECRETION 4 0.0004
472 HALLUCINATION 30 0.0004
473 RESPIRATORY FAILURE 29 0.0004
474 EMPHYSEMA 4 0.0004
475 TENDON PAIN 3 0.0004
476 BLOOD COUNT ABNORMAL 6 0.0004
477 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
478 VERTIGO 24 0.0004
479 PROCEDURAL COMPLICATION 3 0.0004
480 HEPATITIS 10 0.0004
481 RENAL FAILURE CHRONIC 3 0.0004
482 HYPOKALAEMIA 18 0.0004
483 INITIAL INSOMNIA 4 0.0004
484 ATRIOVENTRICULAR BLOCK 3 0.0004
485 DEEP VEIN THROMBOSIS 25 0.0004
486 HAEMORRHAGIC STROKE 3 0.0004
487 TENDERNESS 4 0.0004
488 RHABDOMYOLYSIS 16 0.0004
489 TORSADE DE POINTES 3 0.0004
490 DISEASE RECURRENCE 18 0.0004
491 PNEUMOTHORAX 6 0.0004
492 RENAL CYST 3 0.0004
493 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
494 AGRANULOCYTOSIS 7 0.0004
495 ABSCESS 6 0.0004
496 ATRIAL FLUTTER 3 0.0004
497 IMPAIRED WORK ABILITY 8 0.0004
498 MEMORY IMPAIRMENT 51 0.0004
499 PRURITUS GENERALISED 8 0.0004
500 FRACTURE 7 0.0004
501 SKIN LACERATION 4 0.0004
502 AGITATION 27 0.0004
503 SKIN LESION 10 0.0004
504 CHOLESTASIS 7 0.0004
505 COGNITIVE DISORDER 17 0.0004
506 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
507 CEREBRAL HAEMORRHAGE 13 0.0004
508 EOSINOPHIL COUNT INCREASED 3 0.0004
509 ARTHROPATHY 20 0.0004
510 PYREXIA 124 0.0004
511 THERAPY NON-RESPONDER 16 0.0004
512 RASH ERYTHEMATOUS 17 0.0004
513 CHROMATURIA 8 0.0004
514 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
515 IMPAIRED DRIVING ABILITY 4 0.0004
516 PRESCRIBED UNDERDOSE 7 0.0004
517 SCAR 6 0.0004
518 PSEUDOMONAS INFECTION 3 0.0003
519 CARDIOGENIC SHOCK 5 0.0003
520 NEOPLASM 4 0.0003
521 MYELODYSPLASTIC SYNDROME 5 0.0003
522 MOVEMENT DISORDER 11 0.0003
523 HIP FRACTURE 11 0.0003
524 LUNG INFILTRATION 3 0.0003
525 HEAD DISCOMFORT 6 0.0003
526 BLOOD IRON DECREASED 4 0.0003
527 CARDIOTOXICITY 3 0.0003
528 HEPATIC FAILURE 10 0.0003
529 LIP DRY 3 0.0003
530 NOCTURIA 4 0.0003
531 CEREBRAL INFARCTION 8 0.0003
532 PNEUMONIA BACTERIAL 3 0.0003
533 NERVOUSNESS 17 0.0003
534 UROSEPSIS 3 0.0003
535 NERVE COMPRESSION 3 0.0003
536 CONJUNCTIVITIS 6 0.0003
537 PRODUCT DISPENSING ERROR 7 0.0003
538 MIDDLE INSOMNIA 6 0.0003
539 LEUKOPENIA 16 0.0003
540 PHOTOPHOBIA 6 0.0003
541 DERMATITIS ALLERGIC 4 0.0003
542 DELIRIUM 11 0.0003
543 MUSCULOSKELETAL DISORDER 6 0.0003
544 DISTURBANCE IN ATTENTION 17 0.0003
545 HALLUCINATION, AUDITORY 5 0.0003
546 METABOLIC ACIDOSIS 10 0.0003
547 ROAD TRAFFIC ACCIDENT 13 0.0003
548 INFUSION SITE PAIN 4 0.0003
549 ANOREXIA 4 0.0003
550 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
551 PRESCRIBED OVERDOSE 6 0.0003
552 DIZZINESS POSTURAL 3 0.0003
553 HAEMATOMA 8 0.0003
554 AUTOIMMUNE DISORDER 3 0.0003
555 PRODUCT AVAILABILITY ISSUE 7 0.0003
556 CONDITION AGGRAVATED 93 0.0003
557 THERAPY CHANGE 3 0.0003
558 LABORATORY TEST ABNORMAL 9 0.0003
559 SHOCK 7 0.0003
560 HYPERGLYCAEMIA 11 0.0003
561 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
562 HYPONATRAEMIA 17 0.0003
563 BONE MARROW FAILURE 6 0.0003
564 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
565 DIZZINESS 147 0.0003
566 MOTOR DYSFUNCTION 3 0.0003
567 BODY TEMPERATURE INCREASED 6 0.0003
568 ABNORMAL LOSS OF WEIGHT 2 0.0003
569 LIVER DISORDER 13 0.0003
570 AKATHISIA 4 0.0003
571 NEUTROPHIL COUNT INCREASED 3 0.0003
572 TACHYCARDIA 26 0.0003
573 PERIPHERAL COLDNESS 4 0.0003
574 TREATMENT FAILURE 24 0.0003
575 HYPERBILIRUBINAEMIA 3 0.0003
576 VENTRICULAR EXTRASYSTOLES 3 0.0003
577 CARDIO-RESPIRATORY ARREST 12 0.0003
578 SEPSIS 32 0.0003
579 WEIGHT FLUCTUATION 3 0.0003
580 CARPAL TUNNEL SYNDROME 4 0.0003
581 SCRATCH 3 0.0003
582 SKIN REACTION 4 0.0003
583 OSTEOARTHRITIS 12 0.0003
584 RENAL PAIN 3 0.0003
585 OSTEONECROSIS OF JAW 7 0.0003
586 LYMPHOCYTE COUNT DECREASED 5 0.0003
587 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
588 MUSCULAR WEAKNESS 32 0.0003
589 DRUG EFFECT DECREASED 15 0.0003
590 OESOPHAGITIS 3 0.0003
591 GASTROENTERITIS 4 0.0003
592 BLINDNESS TRANSIENT 2 0.0003
593 CARDIOMYOPATHY 4 0.0003
594 NERVE INJURY 3 0.0003
595 URINARY RETENTION 9 0.0003
596 HEPATOTOXICITY 6 0.0003
597 PANCYTOPENIA 15 0.0003
598 THINKING ABNORMAL 5 0.0003
599 BLISTER 15 0.0003
600 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
601 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
602 RENAL FAILURE 35 0.0003
603 DERMATITIS CONTACT 3 0.0003
604 CHOLECYSTECTOMY 3 0.0003
605 OEDEMA PERIPHERAL 32 0.0003
606 SLEEP APNOEA SYNDROME 5 0.0003
607 SWELLING FACE 17 0.0003
608 FEAR 7 0.0003
609 JAUNDICE 7 0.0003
610 ACUTE RESPIRATORY FAILURE 5 0.0003
611 MUSCULOSKELETAL CHEST PAIN 4 0.0003
612 URINARY TRACT INFECTION 44 0.0003
613 DELUSION 4 0.0003
614 EJECTION FRACTION DECREASED 4 0.0003
615 EAR PAIN 5 0.0003
616 GASTROINTESTINAL DISORDER 23 0.0003
617 MOOD ALTERED 7 0.0003
618 HYPERKALAEMIA 9 0.0003
619 HYPERHIDROSIS 33 0.0003
620 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
621 AFFECTIVE DISORDER 2 0.0003
622 DYSPHAGIA 24 0.0003
623 SEPTIC SHOCK 11 0.0003
624 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
625 HAEMATOCRIT DECREASED 5 0.0003
626 CYSTITIS 8 0.0003
627 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
628 IRRITABILITY 15 0.0002
629 SENSORY DISTURBANCE 4 0.0002
630 PRODUCT PHYSICAL ISSUE 5 0.0002
631 BLOOD POTASSIUM INCREASED 4 0.0002
632 BLINDNESS 10 0.0002
633 METASTASES TO BONE 4 0.0002
634 OSTEOPOROSIS 10 0.0002
635 ABASIA 6 0.0002
636 ILLNESS 25 0.0002
637 GENERALISED OEDEMA 3 0.0002
638 FEELING ABNORMAL 58 0.0002
639 CYST 3 0.0002
640 ACUTE CORONARY SYNDROME 2 0.0002
641 EXPOSURE DURING PREGNANCY 15 0.0002
642 HYPOAESTHESIA 36 0.0002
643 SECRETION DISCHARGE 3 0.0002
644 ATRIAL SEPTAL DEFECT 2 0.0002
645 INTESTINAL OBSTRUCTION 9 0.0002
646 DERMATITIS 5 0.0002
647 CELLULITIS 12 0.0002
648 WHEEZING 14 0.0002
649 EATING DISORDER 5 0.0002
650 INTENTIONAL OVERDOSE 15 0.0002
651 LIVER FUNCTION TEST INCREASED 5 0.0002
652 ARRHYTHMIA 11 0.0002
653 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
654 NIGHTMARE 8 0.0002
655 PLEURAL EFFUSION 14 0.0002
656 SYNCOPE 23 0.0002
657 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
658 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
659 ANHEDONIA 6 0.0002
660 BEDRIDDEN 3 0.0002
661 ORAL CANDIDIASIS 3 0.0002
662 INJURY 16 0.0002
663 TOOTH INFECTION 3 0.0002
664 EMOTIONAL DISORDER 7 0.0002
665 SOPOR 3 0.0002
666 LIMB DISCOMFORT 7 0.0002
667 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
668 CEREBROVASCULAR ACCIDENT 38 0.0002
669 JOINT RANGE OF MOTION DECREASED 3 0.0002
670 THROMBOCYTOPENIA 25 0.0002
671 PANCREATITIS ACUTE 5 0.0002
672 PRODUCT TASTE ABNORMAL 3 0.0002
673 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
674 HEPATIC ENZYME INCREASED 15 0.0002
675 RESTLESS LEGS SYNDROME 4 0.0002
676 GINGIVAL BLEEDING 3 0.0002
677 BONE DISORDER 4 0.0002
678 CORONARY ARTERY OCCLUSION 3 0.0002
679 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
680 ANAPHYLACTIC REACTION 12 0.0002
681 ATRIAL FIBRILLATION 21 0.0002
682 EYE SWELLING 8 0.0002
683 DEMENTIA 6 0.0002
684 MASS 3 0.0002
685 BLOOD CHOLESTEROL INCREASED 10 0.0002
686 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
687 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
688 HEPATIC CIRRHOSIS 4 0.0002
689 BLINDNESS UNILATERAL 3 0.0002
690 ABORTION INDUCED 2 0.0002
691 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11 0.0002
692 VISUAL ACUITY REDUCED 7 0.0002
693 CHRONIC KIDNEY DISEASE 16 0.0002
694 PROTEINURIA 4 0.0002
695 DIABETES MELLITUS 16 0.0002
696 SKIN DISORDER 7 0.0002
697 GAIT INABILITY 7 0.0002
698 LOWER LIMB FRACTURE 4 0.0002
699 DRUG PRESCRIBING ERROR 4 0.0002
700 HYPERTHYROIDISM 3 0.0002
701 RASH 90 0.0002
702 MUSCULOSKELETAL STIFFNESS 18 0.0002
703 COMPLETED SUICIDE 17 0.0002
704 LIVER INJURY 5 0.0002
705 ANGIOEDEMA 9 0.0002
706 BODY TEMPERATURE DECREASED 2 0.0002
707 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
708 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
709 SKIN HAEMORRHAGE 3 0.0002
710 EXTRAPYRAMIDAL DISORDER 5 0.0002
711 PULMONARY OEDEMA 9 0.0002
712 SPINAL FRACTURE 4 0.0002
713 BONE LOSS 3 0.0002
714 HYPOXIA 7 0.0002
715 GASTROOESOPHAGEAL REFLUX DISEASE 16 0.0002
716 DEVICE FAILURE 3 0.0002
717 TINNITUS 9 0.0002
718 MOBILITY DECREASED 14 0.0002
719 ANKLE FRACTURE 3 0.0002
720 THERAPY PARTIAL RESPONDER 3 0.0002
721 PANIC ATTACK 7 0.0002
722 BONE DENSITY DECREASED 6 0.0002
723 BRAIN FOG 3 0.0002
724 MUCOSAL INFLAMMATION 5 0.0002
725 OVERDOSE 41 0.0002
726 KNEE ARTHROPLASTY 4 0.0002
727 VISION BLURRED 26 0.0002
728 EAR INFECTION 5 0.0002
729 RETCHING 4 0.0002
730 WEIGHT DECREASED 52 0.0002
731 ASTHENIA 70 0.0002
732 HYPOGLYCAEMIA 9 0.0002
733 VOMITING 87 0.0002
734 HEADACHE 116 0.0002
735 ERYTHEMA 38 0.0002
736 THROAT TIGHTNESS 5 0.0002
737 RASH PRURITIC 10 0.0002
738 HYPERSENSITIVITY 34 0.0002
739 ACUTE KIDNEY INJURY 28 0.0002
740 IMPAIRED HEALING 6 0.0002
741 EYE DISORDER 6 0.0002
742 MANIA 3 0.0002
743 THERAPEUTIC RESPONSE DECREASED 11 0.0002
744 BLOOD PRESSURE DECREASED 12 0.0002
745 DIVERTICULITIS 5 0.0002
746 FUNGAL INFECTION 6 0.0002
747 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
748 HAEMOPTYSIS 5 0.0002
749 GLOSSODYNIA 4 0.0002
750 RENAL IMPAIRMENT 15 0.0002
751 RASH PAPULAR 4 0.0002
752 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
753 SKIN EXFOLIATION 15 0.0002
754 TARDIVE DYSKINESIA 5 0.0002
755 HEART RATE IRREGULAR 4 0.0002
756 INSOMNIA 47 0.0002
757 DEPRESSION 40 0.0002
758 RED BLOOD CELL COUNT DECREASED 5 0.0002
759 ANAEMIA 33 0.0002
760 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
761 DRY MOUTH 14 0.0002
762 HAEMORRHAGE 18 0.0002
763 HEART RATE DECREASED 6 0.0002
764 PANCREATITIS 9 0.0002
765 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
766 BACTERAEMIA 2 0.0002
767 RENAL INJURY 5 0.0002
768 PRODUCT PRESCRIBING ERROR 4 0.0002
769 GOUT 3 0.0002
770 WITHDRAWAL SYNDROME 7 0.0002
771 DIABETIC KETOACIDOSIS 4 0.0002
772 GASTROENTERITIS VIRAL 3 0.0002
773 OSTEOMYELITIS 3 0.0002
774 SUICIDE ATTEMPT 10 0.0002
775 C-REACTIVE PROTEIN INCREASED 6 0.0002
776 ADRENAL INSUFFICIENCY 2 0.0002
777 RESTLESSNESS 6 0.0002
778 PNEUMONIA 53 0.0002
779 ABDOMINAL DISTENSION 17 0.0002
780 HYPOACUSIS 7 0.0002
781 CARDIAC FAILURE 13 0.0002
782 NEUTROPENIA 22 0.0002
783 FEMUR FRACTURE 5 0.0002
784 HEPATIC STEATOSIS 3 0.0002
785 BLOOD URINE PRESENT 3 0.0002
786 GASTRIC ULCER 3 0.0002
787 HAEMATEMESIS 4 0.0002
788 CARDIOVASCULAR DISORDER 4 0.0002
789 FEELING JITTERY 3 0.0002
790 MOOD SWINGS 5 0.0002
791 CONTUSION 15 0.0002
792 GLAUCOMA 3 0.0002
793 ANAPHYLACTIC SHOCK 4 0.0002
794 LACTIC ACIDOSIS 5 0.0002
795 CHOKING 3 0.0002
796 RESPIRATORY TRACT INFECTION 4 0.0002
797 DEAFNESS 4 0.0002
798 DYSPEPSIA 15 0.0002
799 SKIN DISCOLOURATION 7 0.0002
800 OSTEONECROSIS 5 0.0002
801 GASTRITIS 4 0.0002
802 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
803 SINUS DISORDER 3 0.0002
804 CATARACT 9 0.0002
805 BLOOD PRESSURE ABNORMAL 3 0.0002
806 VIRAL INFECTION 5 0.0002
807 PREGNANCY 3 0.0001
808 ABORTION SPONTANEOUS 6 0.0001
809 SWELLING 14 0.0001
810 CARDIAC FAILURE CONGESTIVE 12 0.0001
811 THROMBOSIS 12 0.0001
812 FULL BLOOD COUNT DECREASED 3 0.0001
813 INTENTIONAL SELF-INJURY 3 0.0001
814 TYPE 2 DIABETES MELLITUS 5 0.0001
815 BLOOD BILIRUBIN INCREASED 4 0.0001
816 FEEDING DISORDER 3 0.0001
817 ANGER 5 0.0001
818 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
819 OEDEMA 8 0.0001
820 NEUTROPHIL COUNT DECREASED 6 0.0001
821 EPISTAXIS 11 0.0001
822 PNEUMONITIS 4 0.0001
823 MALAISE 64 0.0001
824 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
825 OFF LABEL USE 127 0.0001
826 PULMONARY HYPERTENSION 3 0.0001
827 POLLAKIURIA 6 0.0001
828 APHONIA 2 0.0001
829 MOUTH ULCERATION 3 0.0001
830 EYE PAIN 8 0.0001
831 JOINT INJURY 3 0.0001
832 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
833 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
834 INFECTION 20 0.0001
835 APATHY 2 0.0001
836 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
837 SINUSITIS 14 0.0001
838 HAEMOGLOBIN DECREASED 14 0.0001
839 MELAENA 3 0.0001
840 MIGRAINE 13 0.0001
841 DYSURIA 5 0.0001
842 FEBRILE NEUTROPENIA 9 0.0001
843 ACUTE MYOCARDIAL INFARCTION 4 0.0001
844 CHEST PAIN 25 0.0001
845 ORAL PAIN 3 0.0001
846 NAUSEA 106 0.0001
847 RESPIRATORY DISORDER 4 0.0001
848 CONSTIPATION 29 0.0001
849 PREMATURE BABY 4 0.0001
850 DEPRESSED MOOD 7 0.0001
851 ANXIETY 37 0.0001
852 PERICARDIAL EFFUSION 3 0.0001
853 VISUAL IMPAIRMENT 16 0.0001
854 COUGH 36 0.0001
855 ALOPECIA 25 0.0001
856 PRODUCTIVE COUGH 6 0.0001
857 MULTIPLE SCLEROSIS 6 0.0001
858 NIGHT SWEATS 4 0.0001
859 LOCALISED INFECTION 3 0.0001
860 HYPERTENSION 26 0.0001
861 BLOOD CREATININE INCREASED 8 0.0001
862 PSORIASIS 16 0.0001
863 INJECTION SITE URTICARIA 3 0.0001
864 CHOLELITHIASIS 4 0.0001
865 PLATELET COUNT DECREASED 13 0.0001
866 LUNG NEOPLASM MALIGNANT 5 0.0001
867 STAPHYLOCOCCAL INFECTION 4 0.0001
868 PRURITUS 46 0.0001
869 BONE PAIN 7 0.0001
870 CHILLS 14 0.0001
871 UNEVALUABLE EVENT 9 0.0001
872 FLUSHING 12 0.0001
873 HYPOPHAGIA 3 0.0001
874 THERAPY CESSATION 6 0.0001
875 RECTAL HAEMORRHAGE 5 0.0001
876 INFLAMMATION 6 0.0001
877 VAGINAL HAEMORRHAGE 5 0.0001
878 DISCOMFORT 7 0.0001
879 MUSCULOSKELETAL PAIN 6 0.0001
880 PARAESTHESIA 18 0.0001
881 INTENTIONAL PRODUCT MISUSE 10 0.0001
882 BURNING SENSATION 8 0.0001
883 ABDOMINAL DISCOMFORT 19 0.0001
884 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
885 FATIGUE 87 0.0001
886 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
887 PAIN OF SKIN 3 0.0001
888 BLOOD PRESSURE INCREASED 17 0.0001
889 PALLOR 3 0.0001
890 CRYING 4 0.0001
891 SUICIDAL IDEATION 10 0.0001
892 NEPHROLITHIASIS 5 0.0001
893 URTICARIA 18 0.0001
894 NECK PAIN 6 0.0001
895 WEIGHT INCREASED 24 0.0001
896 OXYGEN SATURATION DECREASED 6 0.0001
897 DEHYDRATION 14 0.0001
898 ANGINA PECTORIS 3 0.0001
899 DYSPNOEA 59 0.0001
900 BACK PAIN 24 0.0001
901 PALPITATIONS 12 0.0001
902 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
903 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
904 BLOOD POTASSIUM DECREASED 3 0.0001
905 DECREASED APPETITE 23 0.0001
906 STOMATITIS 6 0.0001
907 PAIN 60 0.0001
908 ADVERSE EVENT 9 0.0001
909 HOSPITALISATION 15 0.0001
910 PERIPHERAL SWELLING 15 0.0001
911 ABDOMINAL PAIN UPPER 20 0.0001
912 MENTAL DISORDER 4 0.0001
913 PAIN IN EXTREMITY 27 0.0001
914 JOINT SWELLING 11 0.0001
915 HEART RATE INCREASED 9 0.0001
916 HAEMATOCHEZIA 5 0.0001
917 PRODUCT USE ISSUE 17 0.0001
918 ABDOMINAL PAIN 21 0.0001
919 NEOPLASM MALIGNANT 6 0.0001
920 ARTHRITIS 7 0.0001
921 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
922 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
923 HAEMATURIA 3 0.0001
924 OROPHARYNGEAL PAIN 8 0.0001
925 RENAL DISORDER 4 0.0001
926 SLEEP DISORDER 6 0.0001
927 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
928 PULMONARY EMBOLISM 8 0.0001
929 DIARRHOEA 54 0.0001
930 BLOOD GLUCOSE DECREASED 4 0.0001
931 INTERSTITIAL LUNG DISEASE 4 0.0001
932 EMOTIONAL DISTRESS 10 0.0001
933 DRUG EFFECT INCOMPLETE 3 0.0001
934 MUSCLE SPASMS 15 0.0001
935 LUNG DISORDER 4 0.0001
936 FEELING HOT 5 0.0001
937 INJECTION SITE MASS 3 0.0001
938 AGEUSIA 2 0.0001
939 DRUG WITHDRAWAL SYNDROME 7 0.0001
940 ARTHRALGIA 33 0.0001
941 COLITIS 3 0.0001
942 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
943 CHEST DISCOMFORT 8 0.0001
944 RHINORRHOEA 5 0.0001
945 PLASMA CELL MYELOMA 3 0.0001
946 ECZEMA 4 0.0001
947 INFLUENZA LIKE ILLNESS 6 0.0001
948 INJECTION SITE REACTION 5 0.0001
949 DRUG ABUSE 6 0.0001
950 MYALGIA 12 0.0001
951 NASOPHARYNGITIS 13 0.0001
952 HERPES ZOSTER 4 0.0001
953 MYOCARDIAL INFARCTION 12 0.0001
954 DYSPHONIA 4 0.0001
955 SURGERY 4 0.0001
956 NASAL CONGESTION 4 0.0001
957 ASCITES 2 0.0001
958 PRODUCT DOSE OMISSION ISSUE 20 0.0001
959 DRY SKIN 9 0.0001
960 DEATH 58 0.0001
961 THROAT IRRITATION 3 0.0001
962 ADVERSE DRUG REACTION 6 0.0001
963 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
964 ILL-DEFINED DISORDER 4 0.0001
965 OCULAR HYPERAEMIA 3 0.0001
966 INFLUENZA 7 0.0001
967 RHEUMATOID ARTHRITIS 7 0.0001
968 INCORRECT DOSE ADMINISTERED 14 0.0001
969 PRODUCT DOSE OMISSION 4 0.0001
970 DRUG DOSE OMISSION 10 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
972 DISEASE PROGRESSION 7 0.0001
973 BRONCHITIS 4 0.0001
974 DYSGEUSIA 4 0.0001
975 CARDIAC DISORDER 5 0.0001
976 ASTHMA 6 0.0001
977 INJECTION SITE SWELLING 4 0.0001
978 COVID-19 9 0.0001
979 INFUSION RELATED REACTION 3 0.0000
980 INJECTION SITE PRURITUS 3 0.0000
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
982 PRODUCT QUALITY ISSUE 6 0.0000
983 DRUG DEPENDENCE 7 0.0000
984 BREAST CANCER 4 0.0000
985 BLOOD GLUCOSE INCREASED 8 0.0000
986 THERAPY INTERRUPTED 3 0.0000
987 UNDERDOSE 3 0.0000
988 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
989 PROSTATE CANCER 3 0.0000
990 BLADDER CANCER 2 0.0000
991 INJECTION SITE ERYTHEMA 4 0.0000
992 INJECTION SITE PAIN 7 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
994 NO ADVERSE EVENT 3 0.0000